Geron Corp. (GERN) EVP and CFO David Greenwood sells 14,746 Shares

EVP and CFO of Geron Corp. (GERN, Financial) David Greenwood sells 14,746 shares of GERN on 06/02/2010 at an average price of $5.43 a share.

Geron Corp. has a market cap of $563.4 million; its shares were traded at around $5.78 with and P/S ratio of 326.3.

GERN is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Bruce Kovner of Caxton Associates, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.

CEO Recent Trades:

  • Sell:: President and CEO Thomas Okarma sold 4,671 shares of GERN stock on 05/24/2010 at the average price of 5.11, the price of the stock has increased by 13.11% since.



CFO Recent Trades:

  • Sell:: EVP and CFO David Greenwood sold 3,503 shares of GERN stock on 05/24/2010 at the average price of 5.11, the price of the stock has increased by 13.11% since.



Directors and Officers Recent Trades:

  • Sell:: VP Operations, Regen Med Progs Katharine E. Spink sold 385 shares of GERN stock on 05/24/2010 at the average price of 5.11, the price of the stock has increased by 13.11% since.

  • Sell:: SVP, CSO Regen Med Jane Lebkowski sold 2,336 shares of GERN stock on 05/24/2010 at the average price of 5.11, the price of the stock has increased by 13.11% since.

  • Sell:: SVP Oncology Melissa Kelly Behrs sold 2,336 shares of GERN stock on 05/24/2010 at the average price of 5.11, the price of the stock has increased by 13.11% since.

  • Sell:: SVP Bus Dev, Chief Patnt Couns David Earp sold 2,336 shares of GERN stock on 05/24/2010 at the average price of 5.11, the price of the stock has increased by 13.11% since.

  • Sell:: EVP, CMO, Oncology Stephen Michael Kelsey sold 3,707 shares of GERN stock on 04/28/2010 at the average price of 5.66, the price of the stock has increased by 2.12% since.